New Products In Brief
This article was originally published in The Gray Sheet
The latest product approvals and launches in cardiology, ophthalmology and more.
You may also be interested in...
Merck will use GE Healthcare’s investigational positron emission tomography agent flutemetamol to select patients to enroll in clinical trials for its Alzheimer’s disease drug candidate.
In revised practice guidelines released Sept. 10, the American Heart Association, the Heart Rhythm Society and the American College of Cardiology Foundation say new evidence shows that many patients with mild heart failure can benefit from cardiac resynchronization devices.
Recent launches and approvals include Smith & Nephew’s Legion HK hinge knee implant, Abiomed’s high-flow Impella CP cardiac pump, and Edwards’ ThruPort ProPlege cardioplegia device.